Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

U.S. involvement in WHO flu meetings, the UK's approval of Moderna's RSV vaccine, efforts against a measles outbreak in Texas ...

Health updates cover U.S. involvement in WHO meetings, UK approval of Moderna's RSV vaccine, a Texas measles outbreak, FDA ...

Here are four respiratory illness updates: On a national level, influenza test positivity decreased to 24.5%, while COVID-19 and RSV positivity rates remained steady at 4.3% and 7.1%. Wastewater ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Influenza and RSV cases are 100 % on the rise, Community Health Nurse Mary Beth Jones, East Liverpool City Health District, said. This season there have been 370,000 hospitalizations for Influenza A ...

The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...

The news comes after staffers told NPR that the Centers for Disease Control and Prevention’s 2023 “Wild to Mild” flu vaccine ...

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) ...